PURPOSE: To evaluate whether two commonly used newer platinum-based regimens offer
any advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients …

Purpose: To compare the survival benefit obtained with cisplatin plus gemcitabine, a
cisplatin-based triplet, and nonplatinum sequential doublets in advanced non–small-cell …

Background Single new agents reportedly produce promising response and survival effects,
but platinum-based doublets remain the standard chemotherapy for advanced non-small …

Purpose: Data from two randomized phase III trials were analyzed to evaluate prognostic
factors and treatment selection in the first-line management of advanced non-small cell lung …

BACKGROUND: Non-platinum regimens have been proposed as an alternative to the
platinum-based combinations for treatment of advanced non-small cell lung cancer …

Purpose This meta-analysis was performed to compare the activity, efficacy and toxicity of
platinum-based versus non-platinum-based chemotherapy in patients with advanced non …

Evidence suggests that platinum-based regimens confer a better survival in patients with
non-small cell lung carcinoma (NSCLC). However, evidence is lacking regarding the …

Purpose We compared the efficacy of combination chemotherapy versus single-agent
therapy in patients with advanced non–small-cell lung cancer. Patients and Methods A total …

With best supportive care alone, patients with metastatic non-small-cell lung cancer
(NSCLC) have a median survival of 4 to 5 months and a 1-year survival rate of …

BACKGROUND This meta‐analysis was conducted to compare the effects of single agent
versus combination chemotherapy on response rate, toxicity, and survival of patients with …